| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $9.6M | +117.8% |
| SG&A Expense | $12.4M | +271.1% |
| Operating Income | -$68.8M | +48.5% |
| Net Income | -$70.7M | +47.1% |
| EPS (Basic) | $8.88 | -17.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.7M | -14.1% |
| Current Assets | $3.7M | +6.7% |
| Total Assets | $7.0M | +52.5% |
| Current Liabilities | $4.2M | +498.4% |
| Total Liabilities | $16.1M | +1879.4% |
| Stockholders' Equity | -$9.0M | -338.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.4M | -109.6% |
| Investing Cash Flow | -$1.6M | -51.0% |
| Financing Cash Flow | $24.6M | +60.3% |